Aventi
1 known investors
Aventi is a clinical-stage biopharmaceutical company developing therapeutics for sarcopenia, with plans to treat geriatric sarcopenia and expand to other age-related diseases. It operates in the biotechnology and pharmaceutical industry.
BiotechLongevity